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Abstract
The lesions of fibrocontractive diseases result from an excessive myofibroproliferative response to numerous forms of
inflammatory stimuli, which elicit the net deposition of extracellular matrix (ECM) in the interstitium of the affected tissue.
Hyaluronan (HA), reported to be a key player supporting cellular migration and adherence, is a major component of ECM
that undergoes dynamic regulation during inflammation. The molecular regulation of HA biosynthesis by inflammatory
cytokines on myofibroblasts is not yet completely understood. Here we report the biochemical characteristics of the lung
myofibroblast cell line MRC-5, and we demonstrate that the production of HA by this cell line is inducible by the
proinflammatory cytokine, tumor necrosis factor-K (TNF-K), at the message level of HA synthase (HAS). In TNF-K-
stimulated MRC-5 cells, DNA-binding and competition experiments indicated that the predominant NF^UB binding activity
detected with nuclear extract-stimulated cells is mediated by the p50/p65 complex. Using antisense oligonucleotides, we
confirmed that the TNF-K-stimulation of HA synthesis by MRC-5 cells is dependent on the activation of the p50/p65 NF^UB
complex. These findings indicate that TNF-K production within inflamed tissues may enhance the HA synthesis via the
transcriptional induction of HAS on myofibroblasts, thereby providing a provisional matrix for supporting cellular
migration and adhesion, and that the p50/p65 NF^UB complex that plays an important role in the regulation of HA
production by TNF-K might be an appropriate target for therapeutic compounds to treat tissue fibrosis accompanied by
inflammation. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Characteristic changes in chronic in£ammation
and tissue ¢brosis are the increased synthesis and
degradation of components of the extracellular ma-
trix (ECM). A major macromolecular component of
the ECM that undergoes dynamic regulation during
in£ammation is hyaluronan (HA). HA is a nonsul-
fated, linear glycosaminoglycan consisting of L1,4-
linked repeating disaccharides of glucuronic acid
L1,3-linked to N-acetylglucosamine [1]. HA has
been reported to contribute the control of cell migra-
tion and other fundamental aspects of cell behavior
including di¡erentiation, proliferation and tissue
morphogenesis, and the synthesis of HA is spatially
and temporally regulated [1]. HA is synthesized at
the cell surface by the membrane-bound enzyme,
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HA synthase (HAS), which is a multigene family
encoding distinct isozymes [2^4].
Mohamazadeh et al. recently reported that HA
expression on endothelial cells can be upregulated
by the proin£ammatory cytokines tumor necrosis
factor-K (TNF-K) and interleukin-1L (IL-1L), that
this occurs over an appropriate interval and can be
sustained for a long enough period to enable the
recruitment of cells to a chronically in£amed site,
and that such changes result in enhanced adhesion
reactions [5]. These observations further support a
role for these interactions in in£ammatory conditions
and provide a new impetus for clarifying the mech-
anism of HA regulation in chronic in£ammation.
During wound healing and ¢brocontractive dis-
eases in adults, some ¢broblasts acquire morphologic
and biochemical features of smooth muscle cells (des-
ignated as myo¢broblasts), including the expression
of K-smooth muscle actin (K-SMA) [6]. We have re-
cently shown that the addition of transforming
growth factor-L1 (TGF-L1) stimulates the produc-
tion of HA and enhances the expression of both K-
SMA and calponin-h1 in a human activated Ito cell
line, LI90 [7]. In the stage of hepatic ¢brosis, HA
produced in excess by activated Ito cells, has been
suggested to play an important role in hepatic sinus-
oidal capillarization [8]. Further evidence has sug-
gested that myo¢broblasts able to synthesize ECM
components commonly appear in pulmonary ¢brosis
[9]. Consequently, myo¢broblasts which actively pro-
duce ECM components including HA may play an
important role in the pathogenesis of tissue ¢brosis.
We report here on the biochemical characteristics
of MRC-5 cells, which are human lung myo¢bro-
blasts, and show that the addition of TNF-K to
MRC-5 cells results in a signi¢cant increase of HA
production via HAS activity as a consequence of the
activation of the p50/p65 NF^UB complex.
2. Materials and methods
2.1. Cell culture
MRC-5 cells were purchased from the American
Type Culture Collection (ATCC; Rockville, MD,
USA), and cultured in Dulbecco’s modi¢ed Eagle’s
medium (DMEM; Gibco Laboratories, Grand Is-
land, NY) supplemented with 10% fetal calf serum
(FCS; Gibco), 100 U/ml penicillin (Gibco) and
100 Wg/ml streptomycin (Gibco), at 37‡C under 5%
CO2/95% air. LI90 cells that exhibited characteristics
compatible with those of myo¢broblasts were also
cultured as previously described [7]. For the assay
of HA production, MRC-5 cells were cultured to
con£uence in DMEM. These cells were stimulated
with TNF-K (Amgen Biologicals, Thousand Oaks,
CA) or TGF-L1 (RpD Systems, Minneapolis, MN)
for 48 h. The conditioned medium was collected and
clari¢ed by centrifugation at 12 000Ug for 5 min.
The quantities of HA produced by MRC-5 cells
with or without the addition of TNF-K were meas-
ured in the culture supernatants by a sandwich en-
zyme-binding assay using a Chugai SBPA kit (Chu-
gai Pharmaceuticals, Tokyo, Japan) [10]. Since most
of the synthesized HA is secreted into the culture
media [1], the amount of cell-associated HA was
not determined.
2.2. Hyaluronan synthase assay
MRC-5 cells were cultured to con£uence, washed
twice, and incubated in fresh medium with or with-
out TNF-K (250 U/ml) for 48 h. As the positive
control, we also investigated the e¡ect of TGF-L1
(5 ng/ml) on the activity of HAS in cultured MRC-
5 cells. Cells were suspended with 0.25 M sucrose
containing 10 mM Hepes and 0.5 mM dithiothreitol
(pH 7.2), and cooled in an ice bath during three
cycles of disruption for 5 s each. Large debris in
the suspension was removed by centrifugation at
600Ug for 10 min. The supernatant was collected
and subjected to centrifugation at 105 000Ug for
1 h. The ‘crude membrane’ pellet was suspended in
0.2 ml of 25 mM Hepes^NaOH (pH 7.1), 5 mM
dithiothreitol, 15 mM MgCl2, 1 mM UDP-GlcNAc
(Sigma, St. Louis, MO), 0.05 mM UDP-GlcUA (Na-
kalai Tesque, Kyoto, Japan), and 2.5 WCi UDP-
[14C]GlcUA (DuPont NEN, Wilmington, DE) as de-
scribed previously [2]. The protein content was deter-
mined with a protein assay kit (Bio Rad, Hercules,
CA). After the reaction at 37‡C for 1 h, the mixture
was further incubated with or without 1 turbidity
reducing unit of Streptomyces hyaluronidase (Seika-
gaku, Tokyo) at 37‡C for 1 h and then boiled in the
presence of 1% sodium dodecyl sulfate (SDS).
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[14C]HA was separated by chromatography on a
Superdex HR 10/30 column (Pharmacia Biotech, To-
kyo) and eluted with 0.2 M ammonium acetate, and
1 ml fractions were collected for the determination of
the radioactivity. Radioactivity incorporated into
HA was calculated as Streptomyces hyaluronidase
sensitive radioactivity.
2.3. RNA extraction and ampli¢cation using reverse
transcription^polymerase chain reaction
(RT^PCR)
MRC-5 cells were cultured to con£uence, washed
twice, and incubated in fresh medium with or with-
out the addition of TNF-K (250 U/ml) for 48 h.
Total RNA from the harvest cells was isolated by
the acid guanidinium thiocyanate^phenol-chloroform
method [11], and 2 Wg of total RNA was converted
to cDNA by reverse transcriptase (Superscript, Gib-
co). The ampli¢cation procedure consisted of 30
cycles (94‡C, 40 s; 60‡C, 30 s; 72‡C, 1.5 min) with
the following oligonucleotide primer sets [7,12]. The
calponin h1 forward primer sequence was 5P-GAG
TGT GCA GAC GGA ACT TCA GCC-3P ; the re-
verse was 5P-GTC TGT GCC CAA CTT GGG
GTC-3P (the pair generated a 671 bp fragment).
The K-SMA forward primer was 5P-CCA GCT
ATG TGA AGA AGA GG-3P ; the reverse was 5P-
GTG ATC TCC TTC TGC ATT CGG T-3P (the
pair generated a 965 bp fragment). The human
HAS-1 forward primer sequence was 5P-TGG GGC
GGC AAG CGC GAG GTC ATG TAC ACA GC-
3P ; the reverse was 5P-CAC CAG AGC GCG TTG
TAC AGC CAC TCA CGG AAG TA-3P (the pair
generated a 548 bp fragment). The glyceraldehyde-3-
phosphate dehydrogenase (G3PDH) forward primer
was 5P-CCC ATC ACC ATC TTC CAG GA-3P ; the
reverse was 5P-TTG TCA TAC CAG GAA ATG
AGC-3P (the pair generated a 731 bp fragment).
Each ¢nal PCR product was electrophoresed on a
1% agarose gel.
2.4. Electrophoretic mobility-shift assays
MRC-5 cells were treated separately with di¡erent
activators at 37‡C. Nuclear extracts were prepared as
described above, and electrophoretic gel mobility-
shift assays (EMSA) were run as previously de-
scribed [13]. A double-stranded oligodeoxynucleotide
containing consensus sequences for NF^UB/Rel com-
plexes was purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA) and used as a probe. The
double-stranded DNA probe was labeled with
[32P]ATP by T4 polynucleotide kinase (Promega,
Madison, WI). Nuclear proteins were incubated
with the [32P]ATP-labeled DNA probe for 15 min
at room temperature in a binding bu¡er containing
5 mM MgCl2, 2.5 mM EDTA, 25 mM dithiothreitol,
250 mM NaCl, 50 mM Tris^HCl (pH 7.5), 0.25 mg/
ml poly(dIdC) and 20% glycerol (Promega). Nuclear
proteins were mixed with a 1/10 volume of a loading
bu¡er containing 250 mM Tris^HCl (pH 7.5), 0.2%
bromophenol blue, 0.2% xylene cyanol and 40% glyc-
erol, and then electrophoresed on a 4% polyacryla-
mide gel. Autoradiograms were developed by expos-
ing vacuum-dried gels to X-ray ¢lm at 380‡C with
intensifying screens. An analysis of competition with
unlabeled oligonucleotides was performed using a 20-
fold excess of double-stranded DNA in the binding
reaction and by adding the nuclear extracts as the
last step in the binding assay. Unrelated competitor
oligonucleotides (SP-1 and Oct-1 from Santa Cruz
Biotechnology) were also used. To analyze the pro-
teins involved in the binding to the UB sequence,
supershift assays were carried out using 1 Wg of the
antibodies against human p65, p50, cRel, RelB and
p52 (Santa Cruz Biotechnology).
The speci¢city of binding was also examined by
competition with the unlabeled oligonucleotides and
by supershift assays. For the latter, nuclear extracts
prepared from TNF-K-treated cells were incubated
with the antibodies against some NF^UB/Rel pro-
teins for 30 min at room temperature before the
complex was analyzed by EMSA.
2.5. p50 and p65 subunits of NF^UB antisense
oligonucleotides
We synthesized the phosphorothio analogs of oli-
godeoxynucleotides (ODN) corresponding to the
sense (S) or antisense (AS) sequences £anking the
translation initiation region of the human mRNAs
for p65 and p50 of the NF^UB subunit. The use of
these oligodeoxynucleotides was described previ-
ously, and their sequences are as follows: p65-AS-
ODN, 5P-GGG GAA CAG TTC GTC CAT GGC-
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3P ; p65-S-ODN, 5P-GCC ATG GAC GAA CTG
TTC CCC-3P ; p50-AS-ODN, 5P-TGG ATC ATC
TTC TGC CAT TCT-3P ; p50-S-ODN, 5P-AGA
ATG GCA GAA GAT GAT CCA-3P [14]. These
AS-ODNs have already been successfully used by
others to inhibit the expression of p65 and p50
mRNA [14]. To assess the e¡ect of AS-ODN on
the secretions of HA by MRC-5 cells, the oligonu-
cleotides (10 WM) were added directly to con£uent
cells every 24 h for 72 h, with 250 U/ml of TNF-K
present during the last 48 h. Cells in the wells with S-
ODN were used as the control experiment. In the
presence of either AS-ODN or S-ODN, the viability
of MRC-5 cells was not signi¢cantly di¡erent from
that of the control cells without ODNs. The AS-
ODN experiments were repeated three times with
independently prepared oligonucleotides.
3. Results
3.1. Expression of K-SMA and calponin-h1 mRNA in
MRC-5 cells
We have shown previously that LI90 cells exhibit-
ing both K-SMA and calponin-h1 produce HA, in
addition to hepatocyte growth factor (HGF) [7]. Ka-
malati et al. reported that MRC-5 cells also ex-
pressed HGF gene [15]. In order to determine
whether MRC-5 cells, like LI90 cells, have an inter-
mediate phenotype between that of smooth muscle
cells and ¢broblasts, we analyzed the levels of speci¢c
mRNA transcripts of K-SMA and calponin-h1 by
RT^PCR. The expression of K-SMA and calponin-
h1 in the MRC-5 cells is demonstrated in Fig. 1.
These cells also expressed the mRNA of acidic cal-
Fig. 1. RT^PCR analysis of mRNA of K-SMA, calponin-h1 and G3PDH in MRC-5 cells. PCR-Ampli¢ed products from cDNAs gen-
erated in reverse transcriptase reaction from 2 Wg of total RNA from MRC-5 and LI90 cells using sense and antisense primers speci¢c
for K-SMA, calponin-h1 and G3PDH. LI90 cells exhibited characteristics compatible with those of human liver-derived myo¢bro-
blasts, as previously described [7]. The predicted size of the K-SMA product is 965 bp, that of the calponin-h1 product is 671 bp, and
that of the G3PDH product is 731 bp.
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ponin, which is a non-muscle isoform (data not
shown). The results suggest that MRC-5 cells exhibit
the biochemical features of myo¢broblasts.
3.2. Hyaluronan synthesis on MRC-5 cells
We investigated the e¡ect of TNF-K on the pro-
duction of HA in a cultured human lung myo¢bro-
blast cell line, MRC-5. The results of HA-binding
assay are shown in Fig. 2, where a marked increase
of the HA production by MRC-5 cells after the treat-
ment of TNF-K can be seen. The treatment with
TGF-L1 also produced a signi¢cant increase in the
HA production by MRC-5 cells (Fig. 2A). The e¡ect
of TNF-K on the production rate of HA was similar
to that of TGF-L1. To further examine the range of
concentrations of TNF-K over which HA production
is inducible, MRC-5 cells were treated with the
stimulant at varying concentrations. The results
(Fig. 2B) indicated a dose-dependent relationship be-
tween the HA production and TNF-K concentration.
The major pathway for HA synthesis uses HAS
located at the plasma membrane [2]. To determine
whether the changes observed in the HA production
are dependent on a simple modulation of HA syn-
Fig. 2. E¡ect of TNF-K on hyaluronan (HA) production by
MRC-5 cells. (A) MRC-5 cells were treated with 250 U/ml of
TNF-K or 5 ng/ml of TGF-L1 for 48 h. The cells responded to
the TNF-K and TGF-L1 treatment by producing increased lev-
els of HA. (B) Dose dependence of increased HA levels in re-
sponse to TNF-K treatment for 48 h. Results are the
means þ S.D. from three experiments.
Fig. 3. E¡ect of TNF-K on the activity and mRNA expression
of HAS in MRC-5 cells. (A) The HAS activity of the crude
membrane fraction was determined as described in Section 2 us-
ing a radiolabeled sugar nucleotide. The speci¢c activity is ex-
pressed as pmol of glucuronic acid transferred from UDP-
[14C]glucuronic acid/h per mg protein. The results are the
means þ S.D. for three experiments. (B) PCR-ampli¢ed products
from cDNAs generated in a reverse transcriptase reaction from
2 Wg of total RNA from MRC-5 cells. The predicted size of the
human HAS-1 product is 548 bp. Higher HAS-1 mRNA levels
were observed in the MRC-5 cells cultured in the presence of
either TNF-K or TGF-L1 for 48 h than in the absence of these
cytokines. The results are representative of two individual ex-
periments.
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thesis in MRC-5 cells via the activity of this enzyme,
we stimulated MRC-5 cells with TNF-K and ana-
lyzed the changes in HAS activity using crude mem-
brane fractions of MRC-5 cells. TNF-K induced the
upregulation of HAS activity in MRC-5 cells, and
the TGF-L1 treatment showed a similar e¡ect on
the activity (Fig. 3A). Itano et al. recently reported
the molecular cloning of the human and mouse gene
encoding HAS-1 [2,12]. We analyzed the changes in
the mRNA levels of HAS-1 using RT^PCR in MRC-
5 cells treated with TNF-K or TGF-L1. As shown in
Fig. 3B, the treatment of MRC-5 cells with TNF-K
and that with TGF-L1 resulted in signi¢cant in-
creases in the HAS-1 mRN level. The mRNA levels
of G3PDH were identical in both the absence and
presence of TNF-K, demonstrating that the di¡er-
ence in the expression of HAS-1 mRNA was not
due to variability in gel loading or the degradation
of RNA during extraction. Thus, changes in the lev-
els of both the activity and message for the central
enzyme in the HA biosynthetic pathway appear to be
responsible for the increased HA production by
MRC-5 cells stimulated with TNF-K.
3.3. Role of NF^UB activation on hyaluronan
synthesis in MRC-5 cells
We performed DNA-binding and competition ex-
periments in MRC-5 cells treated with TNF-K using
EMSA, since the treatment of cells with proin£am-
matory cytokines is known to activate NF^UB [16].
To characterize the observed TNF-K-induced DNA-
binding activity, competition experiments were per-
formed with various oligonucleotides. As Fig. 4
shows, the unlabeled oligonucleotide with the bind-
ing site for NF^UB was sensitive to competition by a
20-fold molar excess, but not by unrelated oligonu-
cleotides (SP-1 or Oct-1). The results of these com-
petition experiments show that the TNF-K-inducible
DNA-binding activities are likely to be composed of
NF^UB proteins. The nature of the proteins that
bind to the UB sequences were next characterized
using supershift assays. As Fig. 4 shows, the protein
complexes retained in MRC-5 cells treated with 250
U/ml TNF-K for 30 min corresponded to p50/p50
homodimers (band a) and p50/p65 heterodimers
(band b), respectively. The treatment of the nuclear
extracts with anti-cRel, anti-RelB, or anti-p52 anti-
bodies did not modify the pattern of bands, indicat-
ing the active NF^UB complex composed of two sub-
units (p50 and p65) in the MRC-5 cells treated with
TNF-K. Based on this observation, our subsequent
studies focused on the functional role of the p50/p65
NF^UB complex in the stimulation of HA synthesis
by the addition of TNF-K to MRC-5 cells.
To explore the role of the p50/p65 subunit of NF^
UB in the TNF-K-induced upregulation of HA syn-
thesis, we chose to examine the e¡ects of antisense
oligonucleotides (AS-ODNs) complementary to p65
and p50 on the HA production by MRC-5 cells
stimulated with TNF-K. These AS-ODNs have al-
ready been successfully used by others to inhibit
the expression of p65 and p50 mRNA [14]. The ex-
posure of MRC-5 cells treated with TNF-K to both
the p65 and p50 AS-ODNs resulted in signi¢cantly
Fig. 4. Characterization of DNA^protein complexes detected in
EMSA by competition and antibodies using nuclear extracts
from TNF-K-stimulated MRC-5 cells. Nuclear extracts were
prepared from MRC-5 cells incubated for 30 min with TNF-K
(250 U/ml). Competition assays (lane 2; 20-fold excess of unla-
beled UB consensus oligonucleotide) and unrelated competitor
oligonucleotides (lanes 3 and 4; SP-1 and Oct-1 as other motifs,
respectively) were used to ensure band speci¢city. For the anal-
ysis of the proteins involved in the binding to the UB sequence,
supershift assays were carried out using the indicated antibodies
(lanes 5^9). Arrows indicate the two TNF-K-inducible com-
plexes corresponding to p50/p50 homodimers (band a) and p50/
p65 (band b), respectively.
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lower amounts of HA in the cultures, whereas the
control (sense) oligonucleotides had no e¡ect on
the HA production (Fig. 5). These data suggest
that the p50/p65 subunit of NF^UB is a key factor
in regulating the production of HA by MRC-5 cells
following TNF-K treatment.
4. Discussion
The present ¢ndings revealed that the human lung
myo¢broblast cell line MRC-5 exhibits unique char-
acteristics, in that these cells express both K-SMA
and calponin-h1 to produce HA. The ¢ndings also
indicate that the stimulation of HA synthesis in cul-
tured MRC-5 cells by TNF-K is due to the upregu-
lation of HAS through the activation of the p50/p65
NF^UB complex.
Myo¢broblasts with morphologic and biochemical
features between those of ¢broblasts and of smooth
muscle cells disappear from normal scars during
wound healing, but persist in ¢brotic lesions of
many organs, where they are involved in retractile
phenomena as well as in ECM accumulation [6]. In
a bleomycin-induced lung injury in rats, myo¢bro-
blasts appeared to be one of the major e¡ector cell
types, and an increase of the pulmonary TNF-K pro-
duction led to alveolar damage and collagen deposi-
tion [9]. A recent study indicated that platelet-derived
growth factor-A (PDGF-A)-de¢cient mice had no
signs of alveogenesis in the lungs, and that this was
apparently caused by the loss of alveolar myo¢bro-
blasts [17]. The speci¢c population of myo¢broblasts
therefore appears to play an important role in the
lung organogenesis during mammalian development.
Unfortunately, no cultured cell line of human lung
myo¢broblasts has been reported. Our present results
suggest that MRC-5 cells, which are derived from
human embryonic lung, exhibit biochemical features
of myo¢broblasts, and that these cells are useful both
for exploring the basic biology of ¢brosis accompa-
nied by pulmonary in£ammation and in the context
of pharmacologic studies.
The regulated expression of cell adhesion mole-
cules on myo¢broblasts in response to microenviron-
mental changes is pivotal to the evolution of in£am-
matory responses. Previous studies have indicated
that the elevation of HA in tissues during the in£am-
Fig. 5. Inhibition of HA production by antisense oligonucleotides against p65 and p50 in TNF-K-stimulated MRC-5 cells. MRC-5
cells were allowed to reach con£uence in 24-well plates. The oligonucleotides (10 WM) were added directly to con£uent cells every 24 h
for 72 h, with 250 U/ml of TNF-K present during the last 48 h. Thereafter, the HA production in cell-free supernatants was evaluated
by a sandwich enzyme-binding assay. Results are the means þ S.D. for three experiments.
BBAMCR 14422 5-1-99
T. Ohkawa et al. / Biochimica et Biophysica Acta 1448 (1999) 416^424422
matory process characterizes by increased cell migra-
tion [18,19]. Many cytokines and growth factors have
been shown to modulate the synthesis of HA
[5,20,21]. Further evidence has suggested that HA
generated during in£ammation may have a role in
macrophage activation, including the induction of
cytokines and chemokines [22,23].
The physiological function of HA-rich pericellular
matrices surrounding myo¢broblasts is less well
understood, although HA has been assigned various
physiological functions in the intercellular matrix.
The organization of HA-rich pericellular matrices
(halo) may modulate the cell attachment to ¢brillar
matrix components, thereby facilitating the detach-
ment necessary for locomotion [1]. In addition, the
formation of HA-halos gives cells protection against
cytotoxic lymphocytes and viruses [1,24]. Similarly,
Streptococci can defend themselves against macro-
phages with a HA halo [1].
The biochemical mechanisms of the biosynthesis of
HA induced in cultured myo¢broblasts by stimula-
tory factors are not yet well understood. Most of the
recent studies have detected no signi¢cant changes in
the mRNA levels of HAS in cultured endothelial
cells over only 4 h time course of treatment with
TNF-K [5]. However, it should be noted that there
are multiple vertebrate HAS genes encoding di¡erent
synthases (HAS-1, -2 and -3) [25]. In the present
study, by RT^PCR analysis for HAS-1 as well as
with the measurement of HAS activity, we observed
detectable changes in both the activity and mRNA
levels of HAS that explain the signi¢cant increases of
HA production with the exposure of MRC-5 cells to
TNF-K for 48 h. Thus, the activity of HAS in TNF-
K- or TGF-L1-stimulated MRC-5 cells could be regu-
lated transcriptionally rather than translationally. Of
course, questions remain as to other mechanisms for
the contributions of degradative enzymes and regard-
ing the changes of HAS-2 or -3 mRNA in stimulated
MRC-5 cells.
The NF^UB/Rel transcription factor complex is a
pleiotropic activator which participates in the induc-
tion of a wide variety of cellular genes, including
genes for cytokines such as IL-1, IL-6, IL-8 and
TNF-K, as well as genes for some cell adhesion mol-
ecules including E-selectin, ICAM-1 and VCAM-1
[16]. Recent studies of gene-targeted knockout mice
indicate that NF^UB/Rel transcription factors are
critical regulators of immune responses [26]. There
are ¢ve known mammalian NF^UB/Rel proteins:
Rel (cRel), p65 (RelA), RelB, p50 (NFKB1) and
p52 (NFKB2). NF^UB activity is mediated by a
homo- or heterodimeric combination of the NF^
UB/Rel proteins. NF^UB DNA-binding activity is in-
duced in most cell types by a variety of agents such
as TNF-K, IL-1, intra- and extracellular pathogens,
or reactive oxygen intermediates [16,26]. The speci-
¢city of the NF^UB-mediated response is controlled
by the NF^UB proteins present in the cells and their
binding preference for NF^UB sites in target pro-
moters [16,26]. Our present observations indicate
that the human HAS-1 molecule contains NF^UB
sites within the 5P regulatory region and appears to
be regulated by proin£ammatory stimuli. We have
also observed a predominant role for the p50/p65
complex of NF^UB in the HA production by TNF-
K-stimulated MRC-5 cells, using antisense oligonu-
cleotides. To our knowledge, this is the ¢rst report of
the transcriptional regulation for HAS and of the use
of antisense oligonucleotides against the p50/p65
complex of NF^UB to examine the HA production
on myo¢broblasts. By eliminating the p50/p65 com-
plex of NF^UB from human myo¢broblasts with
antisense oligonucleotides, we rendered these cells
refractory to stimuli by proin£ammatory cytokines,
thus impairing the ability of these cells to adhere to
the substratum. Taken together, these results suggest
that the p50/p65 complex of NF^UB could be an
attractive target for therapeutic compounds against
tissue ¢brosis accompanied by in£ammation.
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